A Study to Assess S-309309 in Healthy and Obese Participants

NCT05247970 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: S-309309
DRUG: Midazolam
DRUG: Placebo

Sponsor

Shionogi